Aitor Uribarri to Risk Factors
This is a "connection" page, showing publications Aitor Uribarri has written about Risk Factors.
Connection Strength
0.082
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed). 2021 Jul; 74(7):608-615.
Score: 0.028
-
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr Metab Cardiovasc Dis. 2021 08 26; 31(9):2619-2627.
Score: 0.007
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Am Heart J. 2021 07; 237:104-115.
Score: 0.007
-
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection. 2021 Aug; 49(4):677-684.
Score: 0.007
-
Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Barc). 2021 07 23; 157(2):58-63.
Score: 0.007
-
Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
Score: 0.007
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
Score: 0.007
-
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19. Eur J Clin Invest. 2021 Jan; 51(1):e13436.
Score: 0.007
-
Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart. 2018 01; 104(2):161-165.
Score: 0.005